Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Head and Neck Neoplasms 3Colonic Neoplasms 3Chronic Pain 3Cancer Pain 3Supratentorial Neoplasms 2Pain, Postoperative 2Pain 2Neoplastic Cells, Circulating 2Neoplasms 2Colorectal Neoplasms 2Agnosia 2Substance Withdrawal Syndrome 1Stomach Neoplasms 1Rectal Neoplasms 1Neoplasm, Residual 1Nasopharyngeal Carcinoma 1Nalbuphine Allergy 1Ileus 1Diverticulosis, Colonic 1Diverticulitis, Colonic 1Constipation 1Breakthrough Pain 1Brain Neoplasms 1Age Problem 1Abdominal Cancer 1

Interventions

Nalbuphine 1Morphine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Nalbuphine Allergy × Morphine × Clear all
NCT05073744 2022-12-29

Nalbuphine Versus Morphine for Perioperative Tumor Ablation

Zhongda Hospital

Phase 4 Unknown
316 enrolled

Nalbuphine Allergy

Data powered by HemOnc (CC BY 4.0) Colophon âš¡